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The diagnosis of thyroid storm is based on the manifesta-
tion of certain clinical features, and it is characterized by
high fever that is difficult to control [1]. It is a life-
threatening condition requiring emergency treatment and
is associated with a high mortality rate.
Therapeutic hypothermia (TH), a recently recommended
postcardiac arrest care option, aims to improve neurolog-
ical outcomes. This treatment is recommended in comatose
(i.e., lack of meaningful response to verbal commands)
adult patients with return of spontaneous circulation
(ROSC) after out-of-hospital ventricular fibrillation cardiac
arrest (CA). The use of TH in patients with ROSC after a
nonshockable CA should be considered on a case-by-case
basis, taking into account the cause of arrest, time until
cardiopulmonary resuscitation (CPR) and ROSC, and un-
derlying comorbidities [2,3].
In the present report, we describe the case of a patient
who received TH after ROSC that was believed to be caused
by thyroid storm. The patient was discharged with a cere-
bral performance category 1 status.
A 37-year-old woman was found to be in an unconscious
state, and was transferred to the emergency department
where CPR was conducted. She was being treated for hy-
perthyroidism (Grave’s disease). However, 15 days previ-
ously, she had voluntarily stopped taking her thyroid
medication. After 8 days, she complained of fever, fatigue,
and dyspnea. When the emergency services arrived, the
patient was barely able to open the door; her heart stopped
on the way to the hospital.
In the emergency department, her initial electrocar-
diogram indicated asystole. After 10 minutes of CPR,
ROSC was observed. The patient was found to have an
enlarged thyroid gland and ophthalmopathy. Moreover,
she had markedly abnormal thyroid function test results:
her thyroid-stimulating hormone level was undetectablehttp://dx.doi.org/10.1016/j.kjms.2014.02.008
1607-551X/Copyright ª 2014, Kaohsiung Medical University. Published b(<0.0025 mIU/mL; normal range, 0.35e4.94 mIU/mL),
her elevated free thyroxine level was 4.07 ng/dL (normal
range, 0.7e1.48 ng/dL), and her triiodothyronine level
was 3.45 ng/mL (normal range, 0.45e1.37 ng/mL).
Thus, TH was recommended as post-CA care. Fig. 1 il-
lustrates the changes in the patient’s body temperature
over time. After ROSC, her body temperature continued to
rise, and reached 40C immediately before TH was per-
formed. Hour 0 refers to the time of ROSC; at that time, her
body temperature was 36.5C. At the start of cooling (Hour
4), her temperature was 40.3C, which decreased toward
the target temperature at Hour 8 (32.7C). The tempera-
ture was 33.1C at the start of rewarming (Hour 32) and was
36.5C at the end of rewarming (Hour 44).
We diagnosed the patient with thyroid storm and initi-
ated treatment with high doses of propylthiouracil, hydro-
cortisone, and Lugol’s solution. During the following 24
hours, the patient was maintained in a hypothermic state at
33C. During the 12 hours, after hypothermia, the patient
underwent rewarming until a normal body temperature of
36.5C was reached. The patient was extubated after 5
days. After 15 days, she exhibited a cerebral performance
category 1 status and was moved to a hospital in her town.
At that time, the patient was alert and sufficiently well to
walk down a hallway unaided.
TH in the post-CA setting is a relatively new treatment
option, and this method may prove to be effective in the
treatment of patients with other conditions. To our
knowledge, the present case is the first to indicate the
successful use of TH in a patient who had previously
experienced CA due to thyroid storm.
In patients with CA caused by thyroid storm, we suggest
that TH care should be considered as a treatment option.
Moreover, we believe that TH may also be effective for
controlling hyperpyrexia caused by thyroid storm in the
absence of CA.y Elsevier Taiwan LLC. All rights reserved.
Figure 1. Change in body temperature during therapeutic hypothermia. The following events occurred: ROSC (Hour 0, 36.5C),
start of cooling (Hour 4, 40.3C), approaching the target temperature (Hour 8, 32.7C), start of rewarming (Hour 32, 33.1C), end of
rewarming (Hour 44, 36.5C). ROSC Z return of spontaneous circulation.
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